NCT07365280: Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma
- State
- Not started
- Phase
- Phase 2
- People
- 78 planned
- Started
- 9 Jan 2026
- Primary completion
- 24 Dec 2028
- Arms
- Experimental
- Results
- None posted
- 26 Jan 2026: Trial registered